Gout
📧 Sign up to get email alerts when something new happens for Gout.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-02-16FDA Approved: ALLOPURINOL — Supplemental Application (Par Health USA, LLC)
The FDA approved a supplemental application for Allopurinol submitted by Par Health USA, LLC.
-
FDA approval · 2024-02-05FDA Approved: ALLOPURINOL — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for allopurinol from Heritage Pharmaceuticals (d/b/a Avet Pharmaceuticals) under ANDA204467. The app…
-
FDA approval · 2024-02-05FDA Approved: ALLOPURINOL — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for ALLOPURINOL (Allopurinol) submitted by Zydus Lifesciences Limited, authorizing changes to the ap…
-
FDA approval · 2024-01-29FDA Approved: ALLOPURINOL — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Allopurinol from Sun Pharmaceutical Industries, Inc., indicating an approved update to the drug'…
-
FDA approval · 2023-11-29FDA Approved: FEBUXOSTAT — Supplemental Application (Tris Pharma Inc)
The FDA approved a supplemental application for febuxostat from Tris Pharma Inc, enabling a generic version of the gout medication.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-11-28FDA Approved: FEBUXOSTAT — Supplemental Application (Solco Healthcare US LLC)
FDA approved a supplemental application for febuxostat from Solco Healthcare US LLC, authorizing changes to the approved product.
-
FDA approval · 2023-11-20FDA Approved: PROBENECID — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for Probenecid filed by Rising Pharma Holdings, Inc., typically related to changes in labeling o…
-
FDA approval · 2023-11-20FDA Approved: PROBENECID — Original Application (Rising Pharma Holdings, Inc.)
The FDA approved Rising Pharma Holdings' original application for a generic probenecid product. Probenecid is a uricosuric agent used to tre…
-
FDA approval · 2023-10-25FDA Approved: FEBUXOSTAT — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for febuxostat submitted by Aurobindo Pharma Limited, authorizing marketing of a generic febuxostat pr…
-
FDA approval · 2023-10-24FDA Approved: PROBENECID AND COLCHICINE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved a generic fixed-dose combination tablet of probenecid and colchicine under ANDA217030 from Rising Pharma Holdings, Inc. for the…
-
FDA approval · 2023-09-28FDA Approved: FEBUXOSTAT — Original Application (Macleods Pharmaceuticals Limited)
FDA approved an original Abbreviated New Drug Application (ANDA) for febuxostat tablets 40 mg and 80 mg by Macleods Pharmaceuticals Limited.…
-
FDA approval · 2023-09-19FDA Approved: FEBUXOSTAT — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for febuxostat filed by Zydus Lifesciences Limited under the ANDA.
-
FDA approval · 2023-09-18FDA Approved: ALLOPURINOL — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for allopurinol submitted by Mylan Pharmaceuticals Inc. (ANDA 018659).
-
FDA approval · 2023-08-15FDA Approved: FEBUXOSTAT — Supplemental Application (Novadoz Pharmaceuticals LLC)
FDA approved a supplemental application for febuxostat from Novadoz Pharmaceuticals LLC.
-
FDA approval · 2023-08-15FDA Approved: FEBUXOSTAT — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved a supplemental application for febuxostat submitted by Ascend Laboratories, LLC.
-
FDA approval · 2023-08-09FDA Approved: FEBUXOSTAT — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for Febuxostat submitted by Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2023-08-09FDA Approved: FEBUXOSTAT — Supplemental Application (DR REDDY'S LABORATORIES LIMITED)
The FDA approved a supplemental application for febuxostat submitted by Dr. Reddy's Laboratories Limited.
-
FDA approval · 2023-08-03FDA Approved: ALLOPURINOL — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' allopurinol via Original Application (ANDA 217748), granting a generic version of the drug.
-
FDA approval · 2023-07-26FDA Approved: FEBUXOSTAT — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for febuxostat from Alembic Pharmaceuticals Limited. The action indicates regulatory approval for a …
-
FDA approval · 2023-07-26FDA Approved: FEBUXOSTAT — Supplemental Application (Hikma Pharmaceuticals USA Inc)
FDA approved a supplemental application for febuxostat by Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2023-06-16FDA Approved: LODOCO — Original Application (AGEPHA Pharma USA, LLC)
FDA approved LODOCO (colchicine tablets 0.5 mg) under an original NDA from AGEPHA Pharma USA, LLC.
-
FDA approval · 2023-04-17FDA Approved: ULORIC — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for ULORIC (febuxostat) submitted by Takeda Pharmaceuticals America, Inc. This action updates th…
-
FDA approval · 2023-03-15FDA Approved: ALLOPURINOL — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
The FDA approved a supplemental application for Allopurinol from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. under ANDA204…
-
FDA approval · 2023-01-12FDA Approved: ALLOPURINOL — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for Allopurinol from Unichem Pharmaceuticals (USA), Inc., indicating approval of a supplement to the…
-
FDA approval · 2023-01-09FDA Approved: FEBUXOSTAT — Original Application (Zydus Lifesciences Limited)
FDA approved Zydus Lifesciences Limited's febuxostat Original Application, granting approval for a generic febuxostat product. Febuxostat is…